OBJECTIVE
States are generally required to collect rebates on physician-administered and pharmacy drugs in order to receive Federal matching funds for those drugs. Previous OIG work identified significant concerns with States' efforts in obtaining rebates for physician-administered drug claims. We will follow-up with select States to determine whether States have implemented controls to ensure ongoing compliance with Federal Medicaid drug rebate requirements.
There are 2 projects in this series.
ACTIVE PROJECTS IN THIS SERIES (2)
TIMELINE
-
October 22, 2025Series Number SRS-A-26-002 Assigned
-
October 22, 2025Projects Announced
Project OAS-26-07-009
-
Project OAS-26-07-010
-
Today2 Audits In-Progress
-
Est FY2027Estimated Fiscal Year for Series Completion